Omar Yasir Shakir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Omar Yasir Shakir has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Safaa Ehssan Atta
Continuing Education Center, Mustansiriyah University
3 shared publications - Karam Gharab
National Diabetes Center, Mustansiriyah University
2 shared publications - Lujain Ali Ghannawi
National Diabetes Center, Mustansiriyah University
2 shared publications Abbas M. Rahmah
Mustansiriyah University
1 shared publicationAsmaa Hamid Khleef
College of Science, University of Anbar, Anbar, Iraq
1 shared publication- Ghufran Salman Jawad
National Diabetes Center, Mustansiriyah University
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 14 (3) , 883-889
INVESTIGATING SERUM SPEXIN LEVELS IN IRAQI PATIENTS WITH ACROMEGALY, WITH AND WITHOUT TYPE 2 DIABETES MELLITUS
Background: Acromegaly is a rare disease with a reported prevalence of 0.006 percent, characterized by excess growth hormone (GH) and insulin-like growth factor (IGF-1). Often leading to metabolic complications such as type 2 diabetes mellitus (T2DM). Spexin is a recently identified peptide involved in energy homeostasis and glucose metabolism. Objectives: This study aims to evaluate serum Spexin levels in acromegaly patients with and without type 2 diabetes mellitus. Materials and Methods: A total of 90 participants were enrolled, 50 patients and 40 controls who attended the Iraqi National Diabetes Center. (different in body mass index, gender, age, and diabetic status). The study parameters, such as Serum growth hormone, insulin-like growth factor-1, and fasting blood Sugar (FBS), were measured, while spexin levels were detected by enzyme-linked immunosorbent assay. This is the first study to estimate Spexin levels in patients with acromegaly. Results: Serum SPX levels were significantly higher in acromegaly patients than in controls (p=0.000). SPX levels also differed considerably across control, diabetic, and non-diabetic acromegaly groups. However, no significant correlation was found between Spexin and any other parameters included in this study. Conclusion: Elevated serum SPX levels in Iraqi patients with acromegaly suggest an involvement in disease pathophysiology; however, the underlying mechanism remains unclear, and further studies are needed to understand the potential role of SPX as a biomarker in acromegaly.
- 30 September 2026
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 14 (3) , 883-889
Open AccessINVESTIGATING SERUM SPEXIN LEVELS IN IRAQI PATIENTS WITH ACROMEGALY, WITH AND WITHOUT TYPE 2 DIABETES MELLITUS
Background: Acromegaly is a rare disease with a reported prevalence of 0.006 percent, characterized by excess growth hormone (GH) and insulin-like growth factor (IGF-1). Often leading to metabolic complications such as type 2 diabetes mellitus (T2DM). Spexin is a recently identified peptide involved in energy homeostasis and glucose metabolism. Objectives: This study aims to evaluate serum Spexin levels in acromegaly patients with and without type 2 diabetes mellitus. Materials and Methods: A total of 90 participants were enrolled, 50 patients and 40 controls who attended the Iraqi National Diabetes Center. (different in body mass index, gender, age, and diabetic status). The study parameters, such as Serum growth hormone, insulin-like growth factor-1, and fasting blood Sugar (FBS), were measured, while spexin levels were detected by enzyme-linked immunosorbent assay. This is the first study to estimate Spexin levels in patients with acromegaly. Results: Serum SPX levels were significantly higher in acromegaly patients than in controls (p=0.000). SPX levels also differed considerably across control, diabetic, and non-diabetic acromegaly groups. However, no significant correlation was found between Spexin and any other parameters included in this study. Conclusion: Elevated serum SPX levels in Iraqi patients with acromegaly suggest an involvement in disease pathophysiology; however, the underlying mechanism remains unclear, and further studies are needed to understand the potential role of SPX as a biomarker in acromegaly.
- Open Access
- 1 June 2026
- Published by Ivan Franko National University of Lviv in Studia Biologica
- Vol. 20 (2) , 81-96
Correlation between mutational profiles in fluoroquinolone resistance genes (gyrA and grlA) and phenotypic antibiotic susceptibility in clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a highly significant multidrug-resistant pathogen that can lead to severe fetal infections in both humans and animals. Fluoroquinolones (FQs) are considered among the antibiotics of choice used to manage MRSA infections. This study addresses rising fluoroquinolone resistance that limits treatment options. Resistance mechanisms typically involve mutations in the gyrA and grlA genes, which encode the drug’s targets. Objective: the aim of this research is to identify the genetic basis for resistance in clinical MRSA isolates. Specifically, the research focused on investigating the distribution of mutations in the gyrA and grlA genes responsible for fluoroquinolone resistance in MRSA isolates obtained from different clinical sources and assessing the correlation of these mutations with phenotypic antibiotic resistance. Materials and Methods. Fifty MRSA isolates collected from various clinical specimens (burn, wound, nose, throat, urine, skin, ear, and operating room samples) were used in the study. Bacteriological methods and PCR detection of the nuc gene confirmed the identification of the isolates. Then, all of the isolates were tested against seven different antibiotics (methicillin, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin, lomefloxacin, and nalidixic acid) using the disk diffusion method and Minimum Inhibitory Concentration (MIC) tests. Twelve isolates exhibiting antibiotic resistance were selected for direct sequence analysis of the gyrA, grlA, and mecA gene regions. The relationship between mutations and resistance was analyzed statistically. Results. All isolates (100 %) carried the mecA gene, and no mutations were detected in this gene. The prevalence of fluoroquinolone resistance was 24 % (12 isolates). Sequence analysis revealed mutations at eight different positions in the gyrA gene (two missense, one deletion, and five silent) and seven different positions in the grlA gene (three missense, one silent, and three insertions). Statistical analysis revealed a significant positive correlation between mutant isolates in the gyrA and grlA genes and fluoroquinolone resistance (p < 0.0001). A significant correlation was also found between nalidixic acid resistance and the presence of mutations (p < 0.009). Conclusion. The findings of this study indicate that a major mechanism of fluoroquinolone resistance in clinical MRSA isolates is the accumulation of mutations in the gyrA and grlA genes, which encode target enzymes, and that these mutations are strongly associated with high-level phenotypic resistance. It has been confirmed that methicillin resistance Are rely to the presence of the mecA gene and does not require a mutation in the gene itself. These results provide deeper insight into the underlying mechanisms of antimicrobial resistance.
- 1 June 2026
- Published by Ivan Franko National University of Lviv in Studia Biologica
- Vol. 20 (2) , 81-96
Open AccessCorrelation between mutational profiles in fluoroquinolone resistance genes (gyrA and grlA) and phenotypic antibiotic susceptibility in clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a highly significant multidrug-resistant pathogen that can lead to severe fetal infections in both humans and animals. Fluoroquinolones (FQs) are considered among the antibiotics of choice used to manage MRSA infections. This study addresses rising fluoroquinolone resistance that limits treatment options. Resistance mechanisms typically involve mutations in the gyrA and grlA genes, which encode the drug’s targets. Objective: the aim of this research is to identify the genetic basis for resistance in clinical MRSA isolates. Specifically, the research focused on investigating the distribution of mutations in the gyrA and grlA genes responsible for fluoroquinolone resistance in MRSA isolates obtained from different clinical sources and assessing the correlation of these mutations with phenotypic antibiotic resistance. Materials and Methods. Fifty MRSA isolates collected from various clinical specimens (burn, wound, nose, throat, urine, skin, ear, and operating room samples) were used in the study. Bacteriological methods and PCR detection of the nuc gene confirmed the identification of the isolates. Then, all of the isolates were tested against seven different antibiotics (methicillin, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin, lomefloxacin, and nalidixic acid) using the disk diffusion method and Minimum Inhibitory Concentration (MIC) tests. Twelve isolates exhibiting antibiotic resistance were selected for direct sequence analysis of the gyrA, grlA, and mecA gene regions. The relationship between mutations and resistance was analyzed statistically. Results. All isolates (100 %) carried the mecA gene, and no mutations were detected in this gene. The prevalence of fluoroquinolone resistance was 24 % (12 isolates). Sequence analysis revealed mutations at eight different positions in the gyrA gene (two missense, one deletion, and five silent) and seven different positions in the grlA gene (three missense, one silent, and three insertions). Statistical analysis revealed a significant positive correlation between mutant isolates in the gyrA and grlA genes and fluoroquinolone resistance (p < 0.0001). A significant correlation was also found between nalidixic acid resistance and the presence of mutations (p < 0.009). Conclusion. The findings of this study indicate that a major mechanism of fluoroquinolone resistance in clinical MRSA isolates is the accumulation of mutations in the gyrA and grlA genes, which encode target enzymes, and that these mutations are strongly associated with high-level phenotypic resistance. It has been confirmed that methicillin resistance Are rely to the presence of the mecA gene and does not require a mutation in the gene itself. These results provide deeper insight into the underlying mechanisms of antimicrobial resistance.
- Open Access
- 1 January 2025
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 13 (3) , 834-847
ANALYSIS OF MECA GENE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ISOLATED FROM A DIVERSE OF CLINICAL SOURCES SPECIMENS
Background: Conventional method was the best method for identifying the Methicillin-resistant gene in Staphylococcus aureus(mecA) due to various species of staphylococci that were expressed for various resistance levels. Objective: This study aimed to get an accurate detection of the mecA gene in S. aureus isolates, which mediates methicillin resistance in bacteria using the primers (mecA) to detect the mutations that occur in the mecA gene encoding for penicillin-binding protein (PBP2a) that is responsible for the intrinsic resistance to all β-lactams. Methods: Fifty clinical isolates were determined as S. aureus according to molecular and bacteriological ways. The susceptibility tests were performed on all bacterial isolates by disc diffusion and MIC methods using methicillin and six fluoroquinolones antibiotics. Results: From fifty isolates, 12 isolates were resistant to methicillin and all six antibiotics; 12 were resistant, three were intermediate, and 38 were sensitive to three or more tested antibiotics, in addition to confirming the resistance of S. aureus isolates by minimum inhibitory concentration test. The primary sources of S. aureus isolates were burns (10%), nose (16%), wounds (8%), operation room (10%), ear (20%), urine (8%), skin (6%), and throat (22%). Twelve resistant isolates were used to examine the mutations in the mecA gene. A direct sequence analysis found no mutations detected in mecA. The methicillin resistance was due to the mecA gene responsible for methicillin resistance. Conclusion: The absence of mutations in the mecA gene implies that resistance may be ascribed to alternative mechanisms, potentially including enhanced expression of penicillin-binding proteins or efflux pumps.
- 1 January 2025
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 13 (3) , 834-847
Open AccessANALYSIS OF MECA GENE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ISOLATED FROM A DIVERSE OF CLINICAL SOURCES SPECIMENS
Background: Conventional method was the best method for identifying the Methicillin-resistant gene in Staphylococcus aureus(mecA) due to various species of staphylococci that were expressed for various resistance levels. Objective: This study aimed to get an accurate detection of the mecA gene in S. aureus isolates, which mediates methicillin resistance in bacteria using the primers (mecA) to detect the mutations that occur in the mecA gene encoding for penicillin-binding protein (PBP2a) that is responsible for the intrinsic resistance to all β-lactams. Methods: Fifty clinical isolates were determined as S. aureus according to molecular and bacteriological ways. The susceptibility tests were performed on all bacterial isolates by disc diffusion and MIC methods using methicillin and six fluoroquinolones antibiotics. Results: From fifty isolates, 12 isolates were resistant to methicillin and all six antibiotics; 12 were resistant, three were intermediate, and 38 were sensitive to three or more tested antibiotics, in addition to confirming the resistance of S. aureus isolates by minimum inhibitory concentration test. The primary sources of S. aureus isolates were burns (10%), nose (16%), wounds (8%), operation room (10%), ear (20%), urine (8%), skin (6%), and throat (22%). Twelve resistant isolates were used to examine the mutations in the mecA gene. A direct sequence analysis found no mutations detected in mecA. The methicillin resistance was due to the mecA gene responsible for methicillin resistance. Conclusion: The absence of mutations in the mecA gene implies that resistance may be ascribed to alternative mechanisms, potentially including enhanced expression of penicillin-binding proteins or efflux pumps.